Injective Partners with Circle to Boost Cross-Chain Trading

Injective, a derivatives-focused blockchain, has partnered with Circle to integrate native USDC support and its Cross-Chain Transfer Protocol (CCTP) into its platform. This move enables traders to access the $79.3 billion liquidity pool of USDC across over 30 blockchains without relying on third-party bridges.

The integration of native USDC changes the collateral game for Injective's trading ecosystem, allowing traders to use the real thing as collateral rather than wrapped versions or synthetic alternatives. This eliminates the need for bridging and reduces the risk associated with it.